These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study. Moekotte AL; Malleo G; van Roessel S; Bonds M; Halimi A; Zarantonello L; Napoli N; Dreyer SB; Wellner UF; Bolm L; Mavroeidis VK; Robinson S; Khalil K; Ferraro D; Mortimer MC; Harris S; Al-Sarireh B; Fusai GK; Roberts KJ; Fontana M; White SA; Soonawalla Z; Jamieson NB; Boggi U; Alseidi A; Shablak A; Wilmink JW; Primrose JN; Salvia R; Bassi C; Besselink MG; Abu Hilal M Br J Surg; 2020 Aug; 107(9):1171-1182. PubMed ID: 32259295 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients. Baghmar S; Agrawal N; Kumar G; Bihari C; Patidar Y; Kumar S; Chattopadhyay TK; Panda D; Arora A; Pamecha V J Gastrointest Cancer; 2019 Sep; 50(3):361-369. PubMed ID: 29464529 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Narang AK; Miller RC; Hsu CC; Bhatia S; Pawlik TM; Laheru D; Hruban RH; Zhou J; Winter JM; Haddock MG; Donohue JH; Schulick RD; Wolfgang CL; Cameron JL; Herman JM Radiat Oncol; 2011 Sep; 6():126. PubMed ID: 21951377 [TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. Krishnan S; Rana V; Evans DB; Varadhachary G; Das P; Bhatia S; Delclos ME; Janjan NA; Wolff RA; Crane CH; Pisters PW Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):735-43. PubMed ID: 17980502 [TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with advanced pancreatic cancer who have progressed on gemcitabine-based therapy. Lee MG; Lee SH; Lee SJ; Lee YS; Hwang JH; Ryu JK; Kim YT; Kim DU; Woo SM Chemotherapy; 2013; 59(4):273-9. PubMed ID: 24457620 [TBL] [Abstract][Full Text] [Related]
10. Ampulla of Vater carcinoma in real-world clinical practice: a case series. Giuliani J; Piacentini P; Bonetti A Tumori; 2015 Jun; 101(3):e75-8. PubMed ID: 25908045 [TBL] [Abstract][Full Text] [Related]
11. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. Neoptolemos JP; Moore MJ; Cox TF; Valle JW; Palmer DH; McDonald AC; Carter R; Tebbutt NC; Dervenis C; Smith D; Glimelius B; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Ghaneh P; Halloran CM; Lerch MM; Oláh A; Rawcliffe CL; Verbeke CS; Campbell F; Büchler MW; JAMA; 2012 Jul; 308(2):147-56. PubMed ID: 22782416 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study. Bolm L; Ohrner K; Nappo G; Rückert F; Zimmermann C; Rau BM; Petrova E; Honselmann KC; Lapshyn H; Bausch D; Weitz J; Sandini M; Keck T; Zerbi A; Distler M; Wellner UF Pancreatology; 2020 Apr; 20(3):433-441. PubMed ID: 31987649 [TBL] [Abstract][Full Text] [Related]
13. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma. Huffman BM; Jin Z; Yadav S; Patel S; Nagorney DM; Truty MJ; McWilliams RR; Halfdanarson TR; Mahipal A Clin Colorectal Cancer; 2019 Sep; 18(3):218-225. PubMed ID: 31178274 [TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma. Assaf E; Verlinde-Carvalho M; Delbaldo C; Grenier J; Sellam Z; Pouessel D; Bouaita L; Baumgaertner I; Sobhani I; Tayar C; Paul M; Culine S Oncology; 2011; 80(5-6):301-6. PubMed ID: 21778770 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer. Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW Am J Clin Oncol; 2016 Aug; 39(4):346-9. PubMed ID: 24755662 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. You DD; Lee HG; Heo JS; Choi SH; Choi DW J Gastrointest Surg; 2009 Sep; 13(9):1699-706. PubMed ID: 19582512 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy following pancreaticoduodenectomy for ampullary adenocarcinoma improves survival in node-positive patients: a propensity score analysis. Kamarajah SK Clin Transl Oncol; 2018 Sep; 20(9):1212-1218. PubMed ID: 29497964 [TBL] [Abstract][Full Text] [Related]
18. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma. Badiyan SN; Olsen JR; Lee AY; Yano M; Menias CO; Khwaja S; Wang-Gillam A; Strasberg SM; Hawkins WG; Linehan DC; Myerson RJ; Parikh PJ Am J Clin Oncol; 2016 Feb; 39(1):1-7. PubMed ID: 26132367 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemoradiotherapy in periampullary cancers--Where does it stand with conformal radiotherapy: A single institution experience. Kapoor R; Bahl A; Bhattacharyya T; Gupta R; Oinam AS J Cancer Res Ther; 2015; 11(2):433-7. PubMed ID: 26148613 [TBL] [Abstract][Full Text] [Related]